Vir Biotechnology Inc VIR:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/06/23 EST
29.50quote price arrow down-0.30 (-1.01%)
Volume
31,690
Close
29.80UNCH (UNCH)
Volume
468,869
52 week range
18.05 - 34.97
Loading...
  • Open29.89
  • Day High30.24
  • Day Low29.51
  • Prev Close29.80
  • 52 Week High34.97
  • 52 Week High Date02/07/22
  • 52 Week Low18.05
  • 52 Week Low Date09/23/22

Key Stats

  • Market Cap3.967B
  • Shares Out133.12M
  • 10 Day Average Volume0.90M
  • Dividend-
  • Dividend Yield-
  • Beta0.19
  • YTD % Change17.74

KEY STATS

  • Open29.89
  • Day High30.24
  • Day Low29.51
  • Prev Close29.80
  • 52 Week High34.97
  • 52 Week High Date02/07/22
  • 52 Week Low18.05
  • 52 Week Low Date09/23/22
  • Market Cap3.967B
  • Shares Out133.12M
  • 10 Day Average Volume0.90M
  • Dividend-
  • Dividend Yield-
  • Beta0.19
  • YTD % Change17.74

RATIOS/PROFITABILITY

  • EPS (TTM)8.50
  • P/E (TTM)3.50
  • Fwd P/E (NTM)-12.45
  • EBITDA (TTM)1.562B
  • ROE (TTM)75.52%
  • Revenue (TTM)2.379B
  • Gross Margin (TTM)91.71%
  • Net Margin (TTM)48.03%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date02/22/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vir Biotechnology Inc

 

Profile

MORE
Vir Biotechnology, Inc. is a commercial-stage immunology company focused on combining immunologic insights with technologies to treat and prevent serious infectious diseases. It has assembled four technology platforms focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid (siRNA), through internal development, collaborations, and acquisitions. The Company's pipeline consists of sotrovimab and other product candidates targeting COVID-19...
Vicki Sato Ph.D.
Independent Chairman of the Board
George Scangos Ph.D.
President, Chief Executive Officer, Director
Johanna Friedl-Naderer
Chief Operating Officer, Executive Vice President
Howard Horn
Chief Financial Officer, Secretary
Ann Hanly Ph.D.
Chief Technology Officer
Address
499 Illinois St Ste 500
San Francisco, CA
94158-2521
United States

Top Peers

SYMBOLLASTCHG%CHG
EXEL
Exelixis Inc
17.27UNCHUNCH
NVAX
Novavax Inc
11.09UNCHUNCH
MRVI
Maravai LifeSciences Holdings Inc
14.48UNCHUNCH
NTRA
Natera Inc
43.78UNCHUNCH
PTCT
PTC Therapeutics Inc
46.23UNCHUNCH